{
  "id": "mhgap#management_6fdfbc80",
  "content": "y The recommendation that sodium valproate is not medicines should be given in recommended\nrecommended in women and girls of childbearing dosages. There is a need to increase awareness of\npotential because of potential harm to the quick intervention, adequate initial benzodiazepine\nfetus, is not included in this question. Since this dosing and timely initiation of second-line treatment\nrecommendation covers the short-term use of in benzodiazepine-resistant cases.\nsodium valproate, the teratogenic effects may vary. y Time to get medical attention is likely to be longer in\nLMICs, so advocacy is needed for better pre-hospital\nmanagement of seizures.\n79\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nEPI3. For adults and children with epilepsy, which antiseizure\nmedicines are effective and safe?\nRecommendation (update): 3.1 Generalized onset seizures:\nMonotherapy with lamotrigine or levetiracetam, or valproic acid (sodium\nvalproate), should be offered as first-line treatment for generalized onset\nseizures in men/boys and women/girls who are not of childbearing potential.\nIn women and girls of childbearing potential with generalized onset seizures,\nlamotrigine or levetiracetam should be offered as first-line monotherapy.\nIf the first monotherapy is not successful for generalized onset seizures, an\nalternative first-line monotherapy should be tried.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Management y The recommendation that sodium valproate is not medicines should be given in recommended\nrecommended in women and girls of childbearing dosages. There is a need to increase awareness of\npotential because of potential harm to the quick intervention, adequate initial benzodiazepine\nfetus, is not included in this question. Since this dosing and timely initiation of second-line treatment\nrecommendation covers the short-term use of in benzodiazepine-resistant cases.\nsodium valproate, the teratogenic effects may vary. y Time to get medical attention is likely to be longer in\nLMICs, so advocacy is needed for better pre-hospital\nmanagement of seizures.\n79\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nEPI3. For adults and children with epilepsy, which antiseizure\nmedicines are effective and safe?\nRecommendation (update): 3.1 Generalized onset seizures:\nMonotherapy with lamotrigine or levetiracetam, or valproic acid (sodium\nvalproate), should be offered as first-line treatment for generalized onset\nseizures in men/boys and women/girls who are not of childbearing potential.\nIn women and girls of childbearing potential with generalized onset seizures,\nlamotrigine or levetiracetam should be offered as first-line monotherapy.\nIf the first monotherapy is not successful for generalized onset seizures, an\nalternative first-line monotherapy should be tried. Y the recommendation that sodium valproate is not medicines should be given in recommended\nrecommended in women and girls of childbearing dosages. there is a need to increase awareness of\npotential because of potential h..."
}